Disciplined Growth Investors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-151,879
| Closed | -$351K | – | 90 |
|
2018
Q2 | $351K | Sell |
151,879
-157,338
| -51% | -$364K | 0.01% | 83 |
|
2018
Q1 | $983K | Sell |
309,217
-5,248
| -2% | -$16.7K | 0.02% | 83 |
|
2017
Q4 | $1.29M | Buy |
314,465
+690
| +0.2% | +$2.83K | 0.03% | 84 |
|
2017
Q3 | $1.42M | Sell |
313,775
-15,325
| -5% | -$69.3K | 0.03% | 83 |
|
2017
Q2 | $1.1M | Buy |
329,100
+4,750
| +1% | +$15.8K | 0.02% | 83 |
|
2017
Q1 | $2.99M | Sell |
324,350
-2,550
| -0.8% | -$23.5K | 0.07% | 84 |
|
2016
Q4 | $2.52M | Buy |
326,900
+25,975
| +9% | +$200K | 0.06% | 84 |
|
2016
Q3 | $3.44M | Sell |
300,925
-4,700
| -2% | -$53.7K | 0.08% | 79 |
|
2016
Q2 | $3.76M | Sell |
305,625
-3,325
| -1% | -$40.9K | 0.09% | 79 |
|
2016
Q1 | $3.12M | Buy |
308,950
+350
| +0.1% | +$3.54K | 0.08% | 82 |
|
2015
Q4 | $6.96M | Sell |
308,600
-1,550
| -0.5% | -$34.9K | 0.18% | 64 |
|
2015
Q3 | $5.15M | Buy |
+310,150
| New | +$5.15M | 0.13% | 70 |
|